Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen- induced cellular transformation

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 10106-10118

  Hermannstädter, Andrea ^a   Ziegler, Christine ^a   Kühl, Marion ^a   Deppert, Wolfgang ^a   Tolstonog, Genrich V ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P300; PROTEIN P53; SCAFFOLD PROTEIN; VIRUS T ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIMIAN VIRUS 40; SUSPENSION CELL CULTURE; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS TRANSFORMATION; WILD TYPE;

3T3 CELLS; ANIMALS; ANTIGENS, VIRAL, TUMOR; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, VIRAL; MICE; MICE, INBRED BALB C; MUTATION; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53;

SIMIAN VIRUS 40;

EID: 70349286027     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00174-09     Document Type: Article

References (98)

1. Aaronson, S. A., and G. J. Todaro. 1968. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J. Cell Physiol. 72:141-148.
2. Ahuja, D., M. T. Saenz-Robles, and J. M. Pipas. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729-7745. (Pubitemid 41670675)
3. 1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity. Proc. Natl. Acad. Sci. USA 100:9524-9529.
4. Bargonetti, J., I. Reynisdottir, P. N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898.
5. Barlev, N. A., L. Liu, N. H. Chehab, K. Mansfield, K. G. Harris, T. D. Halazonetis, and S. L. Berger. 2001. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8:1243-1254.
6. Bocchetta, M., S. Eliasz, M. A. De Marco, J. Rudzinski, L. Zhang, and M. Carbone. 2008. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res. 68:1022-1029. (Pubitemid 351272219)
7. Borger, D. R., and J. A. DeCaprio. 2006. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J. Virol. 80:4292-4303.
8. Boyapati, A., M. Wilson, J. Yu, and K. Rundell. 2003. SV40 17KT antigen complements dnaj mutations in large T antigen to restore transformation of primary human fibroblasts. Virology 315:148-158. (Pubitemid 37340057)
9. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
10. Cole, C. N., J. Tornow, R. Clark, and R. Tjian. 1986. Properties of the simian virus 40 (SV40) large T antigens encoded by SV40 mutants with deletions in gene A. J. Virol. 57:539-546.
11. Conzen, S. D., and C. N. Cole. 1995. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts. Oncogene 11:2295-2302.
12. Courtneidge, S. A., and A. E. Smith. 1984. The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J. 3:585-591.
13. Courtneidge, S. A., and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439.
14. Courtois, S., G. Verhaegh, S. North, M. G. Luciani, P. Lassus, U. Hibner, M. Oren, and P. Hainaut. 2002. ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene 21:6722-6728. (Pubitemid 35221914)
15. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
16. DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
17. DeLeo, A. B., H. Shiku, T. Takahashi, M. John, and L. J. Old. 1977. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med. 146:720-734.
18. Demers, G. W., C. L. Halbert, and D. A. Galloway. 1994. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169-174. (Pubitemid 124018772)
19. Deppert, W., and M. Haug. 1986. Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells. Mol. Cell. Biol. 6:2233-2240.
20. Deppert, W., M. Haug, and T. Steinmayer. 1987. Modulation of p53 protein expression during cellular transformation with simian virus 40. Mol. Cell. Biol. 7:4453-4463.
21. Deppert, W., T. Steinmayer, and W. Richter. 1989. Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation. Oncogene 4:1103-1110. (Pubitemid 19211725)
22. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937. (Pubitemid 19066153)
23. Eckhart, W. 1989. Oncogenes of DNA tumor viruses, p. 223-238. In R. A. Weinberg (ed.), Oncogenes and the molecular origins of cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Eismann, T. 2005. Identifizierung und Charakterisierung einer Verankerungsdomäne auf dem Tumorsuppressorgen p53, welche für die Inaktivierung durch zytoplasmatische Retention verantwortlich ist. Thesis. University of Hamburg, Hamburg, Germany.
25. Eliyahu, D., N. Goldfinger, O. Pinhasi-Kimhi, G. Shaulsky, Y. Skurnik, N. Arai, V. Rotter, and M. Oren. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3:313-321. (Pubitemid 18245293)
26. Eliyahu, D., D. Michalovitz, S. Eliyahu, O. Pinhasi-Kimhi, and M. Oren. 1989. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86:8763-8767.
27. Eliyahu, D., A. Raz, P. Gruss, D. Givol, and M. Oren. 1984. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312:646-649. (Pubitemid 15218336)
28. Espinosa, J. M., and B. M. Emerson. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8:57-69.
29. Fanning, E., K. H. Westphal, D. Brauer, and D. Corlin. 1982. Subclasses of simian virus 40 large T antigen: differential binding of two subclasses of T antigen from productively infected cells to viral and cellular DNA. EMBO J. 1:1023-1028.
30. Ferreon, J. C., C. W. Lee, M. Arai, M. A. Martinez-Yamout, H. J. Dyson, and P. E. Wright. 2009. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc. Natl. Acad. Sci. USA 106:6591-6596.
31. Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093.
32. Fukasawa, K., T. Choi, R. Kuriyama, S. Rulong, and G. F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747. (Pubitemid 26102826)
33. Fukasawa, K., G. Sakoulas, R. E. Pollack, and S. Chen. 1991. Excess wildtype p53 blocks initiation and maintenance of simian virus 40 transformation. Mol. Cell. Biol. 11:3472-3483.
34. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182. (Pubitemid 11173621)
35. Guidez, F., L. Howell, M. Isalan, M. Cebrat, R. M. Alani, S. Ivins, I. Hormaeche, M. J. McConnell, S. Pierce, P. A. Cole, J. Licht, and A. Zelent. 2005. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25:5552-5566.
36. Harada, J. N., A. Shevchenko, D. C. Pallas, and A. J. Berk. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194-9206.
37. Harvey, D. M., and A. J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
38. Harvey, M., A. T. Sands, R. S. Weiss, M. E. Hegi, R. W. Wiseman, P. Pantazis, B. C. Giovanella, M. A. Tainsky, A. Bradley, and L. A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457-2467.
39. Helt, A. M., and D. A. Galloway. 2003. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24:159-169.
40. Henning, W., G. Rohaly, T. Kolzau, U. Knippschild, H. Maacke, and W. Deppert. 1997. MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J. Virol. 71:7609-7618. (Pubitemid 27391703)
41. Herzig, M., M. Novatchkova, and G. Christofori. 1999. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis. Biol. Chem. 380:203-211.
42. Hinds, P., C. Finlay, and A. J. Levine. 1989. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63:739-746. (Pubitemid 19057240)
43. Hinzpeter, M., and W. Deppert. 1987. Analysis of biological and biochemical parameters for chromatin and nuclear matrix association of SV40 large T antigen in transformed cells. Oncogene 1:119-129. (Pubitemid 17144614)
44. Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249-270.
45. Jiang, D., A. Srinivasan, G. Lozano, and P. D. Robbins. 1993. SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8:2805-2812. (Pubitemid 23279109)
46. Joerger, A. C., and A. R. Fersht. 2008. Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 77:557-582.
47. Kitamura, T., Y. Koshino, F. Shibata, T. Oki, H. Nakajima, T. Nosaka, and H. Kumagai. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31:1007-1014.
48. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
49. Lane, D. P., and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263.
50. Levine, A. J. 1990. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177:419-426.
51. Lilyestrom, W., M. G. Klein, R. Zhang, A. Joachimiak, and X. S. Chen. 2006. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20:2373-2382. (Pubitemid 44320386)
52. Linzer, D. I., and A. J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52. (Pubitemid 9188209)
53. Ludlow, J. W., and G. R. Skuse. 1995. Viral oncoprotein binding to pRB, p107, p130, and p300. Virus Res. 35:113-121.
54. Luo, X., D. G. Sanford, P. A. Bullock, and W. W. Bachovchin. 1996. Solution structure of the origin DNA-binding domain of SV40 T-antigen. Nat. Struct. Biol. 3:1034-1039.
55. Manos, M. M., and Y. Gluzman. 1985. Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants. J. Virol. 53:120-127.
56. Manos, M. M., and Y. Gluzman. 1984. Simian virus 40 large T-antigen point mutants that are defective in viral DNA replication but competent in oncogenic transformation. Mol. Cell. Biol. 4:1125-1133.
57. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887. (Pubitemid 33135314)
58. Marchionni, M. A., and D. J. Roufa. 1981. Replication of viral DNA sequences integrated within the chromatin of SV40-transformed Chinese hamster lung cells. Cell 26:245-258.
59. Martin, R. G., and A. Oppenheim. 1977. Initiation points for DNA replication in nontransformed and simian virus 40-transformed Chinese hamster lung cells. Cell 11:859-869.
60. Meinke, G., P. Phelan, S. Moine, E. Bochkareva, A. Bochkarev, P. A. Bullock, and A. Bohm. 2007. The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS Biol. 5:e23. (Pubitemid 46256665)
61. Michalovitz, D., D. Eliyahu, and M. Oren. 1986. Overproduction of protein p53 contributes to simian virus 40-mediated transformation. Mol. Cell. Biol. 6:3531-3536.
62. Minsky, N., and M. Oren. 2004. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol. Cell 16:631-639. (Pubitemid 39531885)
63. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066. (Pubitemid 30398356)
64. Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105. (Pubitemid 20066852)
65. Parada, L. F., H. Land, R. A. Weinberg, D. Wolf, and V. Rotter. 1984. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312:649-651. (Pubitemid 15218337)
66. Poulin, D. L., A. L. Kung, and J. A. DeCaprio. 2004. p53 targets simian virus 40 large T antigen for acetylation by CBP. J. Virol. 78:8245-8253.
67. Prives, C., L. Covey, A. Scheller, and Y. Gluzman. 1983. DNA-binding properties of simian virus 40 T-antigen mutants defective in viral DNA replication. Mol. Cell. Biol. 3:1958-1966.
68. Querido, E., P. Blanchette, Q. Yan, T. Kamura, M. Morrison, D. Boivin, W. G. Kaelin, R. C. Conaway, J. W. Conaway, and P. E. Branton. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15:3104-3117. (Pubitemid 33115675)
69. Quinlan, M. P. 1994. Enhanced proliferation, growth factor induction and immortalization by adenovirus E1A 12S in the absence of E1B. Oncogene 9:2639-2647.
70. Richter, W., and W. Deppert. 1990. The cellular chromatin is an important target for SV40 large T antigen in maintaining the transformed phenotype. Virology 174:543-556. (Pubitemid 20060157)
71. Rogan, E. M., T. M. Bryan, B. Hukku, K. Maclean, A. C. Chang, E. L. Moy, A. Englezou, S. G. Warneford, L. Dalla-Pozza, and R. R. Reddel. 1995. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15:4745-4753.
72. Rovinski, B., and S. Benchimol. 1988. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene 2:445-452. (Pubitemid 18133695)
73. Rundell, K., and R. Parakati. 2001. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin. Cancer Biol. 11:5-13.
74. Sandmeyer, S., R. Smith, D. Kiehn, and P. Bornstein. 1981. Correlation of collagen synthesis and procollagen messenger RNA levels with transformation in rat embryo fibroblasts. Cancer Res. 41:830-838. (Pubitemid 11136321)
75. Sankar, N., S. Baluchamy, R. K. Kadeppagari, G. Singhal, S. Weitzman, and B. Thimmapaya. 2008. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27:5717-5728.
76. Santoso, B., and J. T. Kadonaga. 2006. Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300. Nat. Struct. Mol. Biol. 13:131-139.
77. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136. (Pubitemid 120035062)
78. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3:1101-1108.
79. Schulze-Garg, C., J. Lohler, A. Gocht, and W. Deppert. 2000. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 19:1028-1037. (Pubitemid 30153786)
80. Schutzbank, T., R. Robinson, M. Oren, and A. J. Levine. 1982. SV40 large tumor antigen can regulate some cellular transcripts in a positive fashion. Cell 30:481-490.
81. Segawa, K., A. Minowa, K. Sugasawa, T. Takano, and F. Hanaoka. 1993. Abrogation of p53-mediated transactivation by SV40 large T antigen. Oncogene 8:543-548. (Pubitemid 23093115)
82. Shimazu, T., Y. Komatsu, K. I. Nakayama, H. Fukazawa, S. Horinouchi, and M. Yoshida. 2006. Regulation of SV40 large T-antigen stability by reversible acetylation. Oncogene 25:7391-7400. (Pubitemid 44853430)
83. Simmons, D. T., G. Loeber, and P. Tegtmeyer. 1990. Four major sequence elements of simian virus 40 large T antigen coordinate its specific and nonspecific DNA binding. J. Virol. 64:1973-1983.
84. Staufenbiel, M., and W. Deppert. 1983. Different structural systems of the nucleus are targets for SV40 large T antigen. Cell 33:173-181.
85. Talis, A. L., J. M. Huibregtse, and P. M. Howley. 1998. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273:6439-6445.
86. Tevethia, M. J., J. M. Pipas, T. Kierstead, and C. Cole. 1988. Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of SV40 gene A. Virology 162:76-89.
87. Tiemann, F., and W. Deppert. 1994. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency. Oncogene 9:1907-1915. (Pubitemid 24194157)
88. Tiemann, F., and W. Deppert. 1994. Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J. Virol. 68:2869-2878. (Pubitemid 24129734)
89. Tiemann, F., J. Zerrahn, and W. Deppert. 1995. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J. Virol. 69:6115-6121.
90. Tjian, R., G. Fey, and A. Graessmann. 1978. Biological activity of purified simian virus 40 T antigen proteins. Proc. Natl. Acad. Sci. USA 75:1279-1283.
91. Tsukada, T., Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda, S. Abe, et al. 1993. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322. (Pubitemid 23342629)
92. Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129. (Pubitemid 18165107)
93. Yin, Y., C. W. Stephen, M. G. Luciani, and R. Fahraeus. 2002. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 4:462-467.
94. Zerrahn, J., and W. Deppert. 1993. Analysis of simian virus 40 small t antigen-induced progression of rat F111 cells minimally transformed by large T antigen. J. Virol. 67:1555-1563. (Pubitemid 23067663)
95. Zerrahn, J., W. Deppert, D. Weidemann, T. Patschinsky, F. Richards, and J. Milner. 1992. Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene 7:1371-1381.
96. Zerrahn, J., F. Tiemann, and W. Deppert. 1996. Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen. J. Virol. 70:6781-6789. (Pubitemid 26307386)
97. Zhao, L. Y., and D. Liao. 2003. Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. J. Virol. 77:13171-13181.
98. Zhu, J. Y., P. W. Rice, M. Chamberlain, and C. N. Cole. 1991. Mapping the transcriptional transactivation function of simian virus 40 large T antigen. J. Virol. 65:2778-2790.